Financing On Target For A Stellar Year

Financing On Target For A Stellar Year
It’s beginning to look a lot like 2001 – or better. In the first nine months of 2003, biotech companies raised nearly $11.8 billion in new funds (excluding revenues and payments from corporate partners), putting the sector on track for at least equaling – if not topping -the $14.7 billion raised in 2001. We’ve already beat 2002’s total of $10.9 billion for the year and chances are excellent that 2003 will turn out to be the second-best fund-raising year ever.

Click here for reuse options!
Copyright 2003 Biotechblog

Leave a Reply

%d bloggers like this: